InBody Co

InBody Co FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of InBody Co (041830.KQ) as of Oct 25, 2026 is 92.57 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 63.44 % — a change of 45.92% (higher).

FCF Conversion

92.57 %

YoY

45.92%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of InBody Co is 2025 92.57 % . FCF Conversion Rate (FCF/EBITDA) of InBody Co was 2024 63.44 % . It decreases by 45.92% higher compared to the previous year.

The InBody Co FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
-117.73 KRW
Jan 1, 2019
103.44 KRW
Jan 1, 2020
153.07 KRW
Jan 1, 2021
55.54 KRW
Jan 1, 2022
72.16 KRW
Jan 1, 2023
84.54 KRW
Jan 1, 2024
63.44 KRW
Jan 1, 2025
92.57 KRW
The InBody Co FCF Conversion history
YEARFCF ConversionYoY
92.57 %+45.92%
63.44 %-24.96%
84.54 %+17.15%
72.16 %+29.92%
55.54 %-63.71%
153.07 %+47.98%
103.44 %-187.86%
-117.73 %-271.51%
68.65 %+18.59%
57.89 %+176.13%
20.96 %-78.83%
99.02 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

InBody Co Stock analysis

What does InBody Co do? InBody Co., Ltd. generates revenue through the sale of body composition analyzers under the InBody and Lookin’Body brand names. The InBody series includes models such as InBody720, InBody520, InBody230, InBody R20, InBody S20, InBody S10, and InBody J10, while the Lookin’Body series offers Lookin’Body3.0 and Lookin’Body Basic for measuring proteins, minerals, fats, and moisture. The company also sells BMI measuring devices under the BSM brand. Products are distributed domestically and internationally to meet demand in both markets. The primary customers for InBody’s equipment are healthcare facilities, fitness centers, and wellness providers seeking accurate body composition data. The InBody series targets professional and clinical settings, whereas Lookin’Body products cater to general wellness and fitness applications. BSM devices serve as complementary tools for body mass index tracking in similar environments. InBody Co., Ltd. focuses on selling medical equipment directly to end-users and distributors, with no mention of third-party partnerships or additional revenue streams. The company’s product portfolio is designed to address diverse needs within the health and fitness industry, leveraging its established brand names for market penetration. InBody Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about InBody Co stock

FCF Conversion Rate (FCF/EBITDA) of InBody Co is 92.57 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of InBody Co changed from 63.44 % to 92.57 %, representing a 45.92% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) InBody Co since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s InBody Co with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — InBody Co

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — InBody Co